Steven Cohen's AMPH Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 54,964 shares of Amphastar Pharmaceuticals, Inc. (AMPH) worth $1.11 M, representing 0.00% of the portfolio. First purchased in 2017-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in AMPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 262,400 shares. Largest reduction occurred in Q3 2024, reducing 197,019 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Amphastar Pharmaceuticals (AMPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amphastar Pharmaceuticals (AMPH) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +54,964 | New Buy | 54,964 | $20.18 |
| Q1 2025 | -9,200 | Sold Out | 0 | $0.00 |
| Q4 2024 | -29,617 | Reduce 76.30% | 9,200 | $37.13 |
| Q3 2024 | -197,019 | Reduce 83.54% | 38,817 | $48.53 |
| Q2 2024 | -26,564 | Reduce 10.12% | 235,836 | $40.00 |
| Q1 2024 | +262,400 | New Buy | 262,400 | $43.91 |
| Q4 2023 | -1,283 | Sold Out | 0 | $0.00 |
| Q3 2023 | +1,283 | New Buy | 1,283 | $45.99 |
| Q2 2023 | -65,418 | Sold Out | 0 | $0.00 |
| Q1 2023 | +65,418 | New Buy | 65,418 | $37.50 |
| Q3 2019 | -162,286 | Sold Out | 0 | $0.00 |
| Q2 2019 | +162,286 | New Buy | 162,286 | $21.11 |
| Q2 2018 | -65,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | -29,820 | Reduce 31.45% | 65,000 | $18.75 |
| Q4 2017 | +94,820 | New Buy | 94,820 | $19.24 |
| Q3 2017 | -175,000 | Sold Out | 0 | $0.00 |
| Q2 2017 | +175,000 | New Buy | 175,000 | $17.86 |
Steven Cohen's Amphastar Pharmaceuticals Investment FAQs
Steven Cohen first purchased Amphastar Pharmaceuticals, Inc. (AMPH) in Q2 2017, acquiring 175,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Amphastar Pharmaceuticals, Inc. (AMPH) for 17 quarters since Q2 2017.
Steven Cohen's largest addition to Amphastar Pharmaceuticals, Inc. (AMPH) was in Q1 2024, adding 262,400 shares worth $11.52 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 54,964 shares of Amphastar Pharmaceuticals, Inc. (AMPH), valued at approximately $1.11 M.
As of the Q2 2026 filing, Amphastar Pharmaceuticals, Inc. (AMPH) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Amphastar Pharmaceuticals, Inc. (AMPH) was 262,400 shares, as reported at the end of Q1 2024.